IC

Ikarian Capital Portfolio holdings

AUM $494M
1-Year Est. Return 153.64%
This Quarter Est. Return
1 Year Est. Return
+153.64%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$494M
AUM Growth
+$192M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
157
New
Increased
Reduced
Closed

Top Buys

1 +$53M
2 +$33.4M
3 +$27.2M
4
PTCT icon
PTC Therapeutics
PTCT
+$17.2M
5
RAPT icon
RAPT Therapeutics
RAPT
+$15.9M

Top Sells

1 +$21.6M
2 +$18.5M
3 +$17.9M
4
COGT icon
Cogent Biosciences
COGT
+$14.7M
5
VRNA
Verona Pharma
VRNA
+$13.9M

Sector Composition

1 Healthcare 99.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KPTI icon
101
Karyopharm Therapeutics
KPTI
$116M
$178K 0.02%
27,257
COGT icon
102
Cogent Biosciences
COGT
$5.98B
$162K 0.02%
11,280
-1,024,248
AIRS icon
103
AirSculpt Technologies
AIRS
$152M
$144K 0.01%
17,951
CMMB
104
Chemomab Therapeutics
CMMB
$10.2M
$140K 0.01%
53,262
-1
LYRA icon
105
Lyra Therapeutics
LYRA
$3.53M
$139K 0.01%
21,161
PMVP icon
106
PMV Pharmaceuticals
PMVP
$60.1M
$137K 0.01%
+97,500
MGNX icon
107
MacroGenics
MGNX
$109M
$135K 0.01%
80,071
SPRB
108
Spruce Biosciences, Inc. Common Stock
SPRB
$78.7M
$119K 0.01%
13,332
-1
AEMD icon
109
Aethlon Medical
AEMD
$2.84M
$115K 0.01%
15,366
VYNE icon
110
VYNE Therapeutics
VYNE
$18.9M
$97.1K 0.01%
290,000
JSPR icon
111
Jasper Therapeutics
JSPR
$42.8M
$59.8K 0.01%
25,107
TRAW icon
112
Traws Pharma
TRAW
$16.1M
$52.7K 0.01%
28,493
TOVX icon
113
Theriva Biologics
TOVX
$6.97M
$48.6K ﹤0.01%
120,031
SYBX icon
114
Synlogic
SYBX
$13.1M
$34.5K ﹤0.01%
20,422
NMRA icon
115
Neumora Therapeutics
NMRA
$343M
$22.7K ﹤0.01%
12,498
AMIX
116
Autonomix Medical
AMIX
$3.27M
$21.6K ﹤0.01%
20,000
ALT icon
117
Altimmune
ALT
$442M
0
APGE icon
118
Apogee Therapeutics
APGE
$5.52B
-232,047
BIIB icon
119
Biogen
BIIB
$24.1B
-21,516
BMY icon
120
Bristol-Myers Squibb
BMY
$112B
0
CMPS
121
Compass Pathways
CMPS
$706M
0
CNTA
122
Centessa Pharmaceuticals
CNTA
$3.28B
0
CRBP icon
123
Corbus Pharmaceuticals
CRBP
$146M
0
ELDN icon
124
Eledon Pharmaceuticals
ELDN
$159M
-1,000,221
KALV icon
125
KalVista Pharmaceuticals
KALV
$738M
-198,528